Bluejay Therapeutics

BiotechnologySeries CSan Francisco, USbluejaytx.com

Latest round

Series C

Last raised

May 2024

Total raised

$203M

Investors

13

About Bluejay Therapeutics

Founded in 2020 and based in California, US, Bluejay Therapeutics Inc. operates as a therapeutic medicine developer for treating infectious diseases such as HBV infection.for USD 620 million. The company offers two main product candidates: BJT-778, a human anti-HBsAg monoclonal antibody with a considerably better pharmacological profile than antibodies currently in development (potency, epitope, safety); and BJT-754, an oral curative HBsAg inhibitor that is the ideal combination partner. The acquisition enables Mirum to add brelovitug, a late-stage hepatitis D therapy, strengthening its rare liver disease portfolio and pipeline.

Who invested in Bluejay Therapeutics

13 investors across 2 rounds

See all investors in Bluejay Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    May 1, 2024

    Amount

    $182M

    Investors

    Locked

  2. Series B

    Aug 9, 2022

    Amount

    $21M

    Investors

    Locked

Questions about Bluejay Therapeutics

Who invested in Bluejay Therapeutics?

Bluejay Therapeutics has 13 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Bluejay Therapeutics raised?

Bluejay Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Bluejay Therapeutics last raise money?

Bluejay Therapeutics's most recent round on record is a Series C, in May 2024.

What does Bluejay Therapeutics do?

Founded in 2020 and based in California, US, Bluejay Therapeutics Inc.

Where is Bluejay Therapeutics headquartered?

Bluejay Therapeutics is headquartered in San Francisco, US.

Which VCs invest in companies like Bluejay Therapeutics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Bluejay Therapeutics's stage. Their profiles are linked below.

Raising like Bluejay Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.